Brief: Cassava Sciences Enters Into Sales Agreement
May 1 (Reuters) - Cassava Sciences Inc SAVA.O :
* CASSAVA SCIENCES - ON MAY 1, CO ENTERED INTO CAPITAL ON
DEMAND
SALES AGREEMENT WITH JONESTRADING INSTITUTIONAL SERVICES LLC, AS
AGENT
* CASSAVA SCIENCES- MAY OFFER & SELL, FROM TIME TO TIME
THROUGH OR
TO AGENT, SHARES OF CO’S COMMON STOCK, HAVING AGGREGATE OFFERING
PRICE OF UP TO $200 MILLION
Source text for Eikon: ID:
Further company coverage: SAVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Filana Therapeutics
See all newsCassava Sciences says US DOJ has closed investigation into company (updated)
Cassava Sciences rises after US DOJ closes probe into company
Cassava Sciences says US DOJ has closed investigation into company
Brief: Cassava Announces Agreement To Settle Securities Class Action Litigation
Brief: Cassava Sciences Inc - On Dec 15, FDA Places Full Clinical Hold On Cassava's Trial - SEC Filing